Wednesday 03.10.2018

ViroVet receives grant from VLAIO (Flanders) to boost the development of its disruptive vaccine technology

LEUVEN, Belgium, 18 September 2018 – ViroVet NV announced today that it has received a 590k€ grant from Flanders Innovation & Entrepreneurship (VLAIO) to assess the potential of its PLLAV-vaccination technology in poultry and large ruminants.

Full Press Release Virovet (EN)